Effects of Insulin-Like Growth Factor (IGF)-I/IGF-Binding Protein-3 Treatment on Glucose Metabolism and Fat Distribution in Human Immunodeficiency Virus-Infected Patients with Abdominal Obesity and Insulin Resistance

Context: HIV-infected patients on antiretroviral therapy are at increased risk for excess visceral adiposity and insulin resistance. Treatment with GH decreases visceral adiposity but worsens glucose metabolism. IGF-I, which mediates many of the effects of GH, improves insulin sensitivity in HIV-neg...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rao, Madhu N., Mulligan, Kathleen, Tai, Viva, Wen, Michael J., Dyachenko, Artem, Weinberg, Melissa, Li, Xiaojuan, Lang, Thomas, Grunfeld, Carl, Schwarz, Jean-Marc, Schambelan, Morris
Formato: Artigo
Lenguaje:Inglês
Publicado: The Endocrine Society 2010
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2936071/
https://ncbi.nlm.nih.gov/pubmed/20610601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2009-2502
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares